"Prof. Dr. Andreas Raabe ist ein international anerkannter Neurochirurg und Direktor der Universitätsklinik für Neurochirurgie des Inselspitals Bern. Hirntumoren, Aneurysmen und die minimalinvasive Wirbelsäulenchirurgie sind seine Schwerpunkte. Dank einer von ihm entwickelten hochmodernen kontinuierlichen Überwachungsmethode bei der Operation von Hirntumoren ist die Erfolgsrate dieser Eingriffe am Inselspital eine der höchsten weltweit. 2019 erhielt Andreas Raabe den renommierten European Lecture Award der Europ. Gesellschaft für Neurochirurgie. 2020 wurde er im Team mit zwei Mitarbeitern der Carl Zeiss AG für den Deutschen Zukunftspreis nominiert und in Anerkennung für höchste wissenschaftliche Innovation vom Dt. Bundespräsidenten geehrt."

During the past decade, Dep. of Neurosurgery, Bern University Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dep. of Neurosurgery, Bern University Hospital" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Dep. of Neurosurgery, Bern University Hospital" are "Subarachnoid Hemorrhage" (3 trials), "Glioblastoma" (2 trials), "Surgery" (2 trials), "AVM" (1 trials) and "Aneurysm" (1 trials). Many other conditions were trialed in "Dep. of Neurosurgery, Bern University Hospital" in a lesser frequency.

Most popular intervention types in "Dep. of Neurosurgery, Bern University Hospital" are "Device" (6 trials), "Other" (3 trials), "Procedure" (3 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Burst DBS" (1 trials), "CONVIVO" (1 trials), "Clinical Testing" (1 trials), "Clinical assessment" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dep. of Neurosurgery, Bern University Hospital" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Dep. of Neurosurgery, Bern University Hospital". 1 are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Dep. of Neurosurgery, Bern University Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Dep. of Neurosurgery, Bern University Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".